Tamuelvicius P, George K C, Rücker A, Streffer C
Institut für Medizinische Strahlenbiologie, Universitätsklinikum Essen, Germany.
Int J Hyperthermia. 1992 May-Jun;8(3):321-8. doi: 10.3109/02656739209021787.
The toxicity of the radiosensitizers misonidazole (MISO), demethylmisonidazole (DEMISO) and pimonidazole (PIM) in mice can be affected differently when combined with local hyperthermia at 43 degrees C for 30 min. At a dose of 1 mg/g, only MISO plus heat resulted in 50% lethality in animals over a period of 7 days post-treatment, whereas 100% survival was observed in the case of DEMISO and PIM. The enhanced lethality may be associated with the production of toxic intermediates of MISO. Heat did not affect the levels of DEMISO in the tissues studied (plasma, brain and tumour), whereas those of PIM were markedly lowered in tumour but not affected in brain for up to 4 h after combined treatment. MISO was found to be decreased in the tumour at all times but affected differently in brain after 1 and 2 h, initially decreasing and then increasing significantly. In all cases the treatment sequence, i.e. sensitizer plus heat or vice-versa, did not affect the rate of survival. At a dose of 2 mg/g, DEMISO plus heat was found to be more toxic when DEMISO was given first (25% survival) compared to 58% on reversal. However, the levels of DEMISO in the tissues were not affected by heat. Thus, it would appear that there is no correlation between parent drug levels measured in plasma, tumour or brain and hyperthermia-induced drug lethality.
当与43摄氏度的局部热疗联合30分钟时,放射增敏剂米索硝唑(MISO)、去甲基米索硝唑(DEMISO)和匹莫硝唑(PIM)对小鼠的毒性可能会受到不同影响。在剂量为1mg/g时,仅MISO加加热会导致动物在治疗后7天内出现50%的致死率,而在DEMISO和PIM的情况下观察到100%的存活率。致死率的增强可能与MISO的毒性中间体的产生有关。热疗不影响所研究组织(血浆、脑和肿瘤)中DEMISO的水平,而联合治疗后长达4小时,PIM在肿瘤中的水平显著降低,但在脑中不受影响。发现MISO在肿瘤中始终降低,但在1小时和2小时后在脑中受到不同影响,最初降低然后显著增加。在所有情况下,治疗顺序,即增敏剂加加热或反之,均不影响存活率。在剂量为2mg/g时,发现先给予DEMISO时,DEMISO加加热更具毒性(25%存活),相比之下,颠倒顺序时为58%存活。然而,组织中DEMISO的水平不受热疗影响。因此,血浆、肿瘤或脑中测得的母体药物水平与热疗诱导的药物致死率之间似乎没有相关性。